These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

643 related items for PubMed ID: 9709006

  • 1. Molecular mechanisms of loss of beta 2-microglobulin expression in drug-resistant breast cancer sublines and its involvement in drug resistance.
    Ogretmen B, McCauley MD, Safa AR.
    Biochemistry; 1998 Aug 18; 37(33):11679-91. PubMed ID: 9709006
    [Abstract] [Full Text] [Related]

  • 2. Negative regulation of MDR1 promoter activity in MCF-7, but not in multidrug resistant MCF-7/Adr, cells by cross-coupled NF-kappa B/p65 and c-Fos transcription factors and their interaction with the CAAT region.
    Ogretmen B, Safa AR.
    Biochemistry; 1999 Feb 16; 38(7):2189-99. PubMed ID: 10026303
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Expression of the mutated p53 tumor suppressor protein and its molecular and biochemical characterization in multidrug resistant MCF-7/Adr human breast cancer cells.
    Ogretmen B, Safa AR.
    Oncogene; 1997 Jan 30; 14(4):499-506. PubMed ID: 9053847
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evidence for transcriptional control of human mdr1 gene expression by verapamil in multidrug-resistant leukemic cells.
    Muller C, Goubin F, Ferrandis E, Cornil-Scharwtz I, Bailly JD, Bordier C, Bénard J, Sikic BI, Laurent G.
    Mol Pharmacol; 1995 Jan 30; 47(1):51-6. PubMed ID: 7838133
    [Abstract] [Full Text] [Related]

  • 10. [Up-regulation of c-myc expression in MCF-7/Adr human breast cancer cells and its association with resistance against doxorubicin].
    Chen J, Yuan YW, Zhang JR, Zhou DY.
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Feb 30; 22(2):124-6. PubMed ID: 12390804
    [Abstract] [Full Text] [Related]

  • 11. Characterization of four doxorubicin adapted human breast cancer cell lines with respect to chemotherapeutic drug sensitivity, drug resistance associated membrane proteins and glutathione transferases.
    de la Torre M, Hao XY, Larsson R, Nygren P, Tsuruo T, Mannervik B, Bergh J.
    Anticancer Res; 1993 Feb 30; 13(5A):1425-30. PubMed ID: 7902062
    [Abstract] [Full Text] [Related]

  • 12. Expression of mRNA coding for TGF-beta and its receptors in irradiated human breast carcinoma MCF-7 cells differing in their sensitivity to doxorubicin.
    Chorna I, Fedorenko O, Datsyuk L, Stoika R.
    Exp Oncol; 2005 Jun 30; 27(2):156-8. PubMed ID: 15995636
    [Abstract] [Full Text] [Related]

  • 13. Relationship between expression of P-glycoprotein and efficacy of trifluoperazine in multidrug-resistant cells.
    Ganapathi R, Kuo T, Teeter L, Grabowski D, Ford J.
    Mol Pharmacol; 1991 Jan 30; 39(1):1-8. PubMed ID: 1670962
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Induction of thymidylate synthase associated with multidrug resistance in human breast and colon cancer cell lines.
    Chu E, Drake JC, Koeller DM, Zinn S, Jamis-Dow CA, Yeh GC, Allegra CJ.
    Mol Pharmacol; 1991 Feb 30; 39(2):136-43. PubMed ID: 1704999
    [Abstract] [Full Text] [Related]

  • 16. Comparative study of human breast carcinoma MCF-7 cells differing in their resistance to doxorubicin: effect of ionizing radiation on apoptosis and TGF-beta production.
    Chorna I, Bilyy R, Datsyuk L, Stoika R.
    Exp Oncol; 2004 Jun 30; 26(2):111-7. PubMed ID: 15273662
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Down-regulation of apoptosis-related bcl-2 but not bcl-xL or bax proteins in multidrug-resistant MCF-7/Adr human breast cancer cells.
    Ogretmen B, Safa AR.
    Int J Cancer; 1996 Sep 04; 67(5):608-14. PubMed ID: 8782646
    [Abstract] [Full Text] [Related]

  • 19. A recombinant adenovirus expressing wild type p53 induces apoptosis in drug-resistant human breast cancer cells: a gene therapy approach for drug-resistant cancers.
    Seth P, Katayose D, Li Z, Kim M, Wersto R, Craig C, Shanmugam N, Ohri E, Mudahar B, Rakkar AN, Kodali P, Cowan K.
    Cancer Gene Ther; 1997 Sep 04; 4(6):383-90. PubMed ID: 9408609
    [Abstract] [Full Text] [Related]

  • 20. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
    Saleh EM, El-Awady RA, Abdel Alim MA, Abdel Wahab AH.
    Cell Biochem Biophys; 2009 Sep 04; 55(2):95-105. PubMed ID: 19593673
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.